Novel polymorphic forms of Troglitazone and methods for preparing the polymorphic forms of Troglitazone. The polymorphic forms of Troglitazone can be used to treat diabetic ailments.

Novel polymorphic forms of Troglitazone and methods for preparing the polymorphic forms of Troglitazone. The polymorphic forms of Troglitazone can be used to treat diabetic ailments.

Compounds of formula (I): Äwhere R<1>, R<2>, R<4> and R<5> are hydrogen or alkyl and R<3> is hydrogen, alkyl or various organic groupsÜ are effective against osteoporosis at doses at which they also effectively control diabetes.

A combination of one or more HMG-CoA reductase inhibitors (for example pravastatin, lovastatin, simvastatin, fluvastatin, rivastatin or atorvastatin) with one or more insulin sensitizers (for example troglitazone, pioglitazone, englitazone, BRL-49653, 5-(4-?2-?1-(4-2'-pyridylphenyl)ethylideneaminooxy?-ethoxy?benzyl?thiaz olidine-2,4-dione, 5-?4-(5-methoxy-3-methylimidazo?5,4-b?pyridin-2-yl-methoxy)benzyl?thia zolidine-2,4-dione or its hydrochloride, 5-?4-(6-methoxy-1-methylbenzimidazol-2-ylmetho...

A combination of one or more HMG-CoA reductase inhibitors (for example pravastatin, lovastatin, simvastatin, fluvastatin, rivastatin or atorvastatin) with one or more insulin sensitizers (for example troglitazone, pioglitazone, englitazone, BRL-49653, 5-(4-{2-1-(4-2'-pyridylphenyl)ethylideneaminooxy!-ethoxy}benzyl)thiazolidine-2,4-dione, 5-{4-(5-methoxy-3-methylimidazo5,4-b!pyridin-2-yl-methoxy)benzyl}thiazolidine-2,4-dione or its hydrochloride, 5-4-(6-methoxy-1-methylbenzimidazol-2-yl methoxy)b...